As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) alongside traditional approaches when planning data generation activities to support new product registration, access, and use. Here we speak with experts from Lumanity about the Integrated Evidence Generation Planning (IEGP) process and how to overcome the barriers to success.